Abstract:Background: The 16p11.2 deletion is one of the most common genetic aetiologies of neurodevelopmental disorders (NDDs). The prenatal phenotype of 16p11.2 deletion and the potential mechanism associated with postnatal clinical manifestations were largely unknow. We revealed the developmental trajectories of 16p11.2 deletion from the prenatal to postnatal periods and to identify key signaling pathways and candidate genes contributing to neurodevelopmental abnormalities. Methods: In this 5-y retrospective cohort study, women with singleton pregnancies who underwent amniocentesis for chromosomal abnormalities were included. Test of copy-number variations (CNVs) involved single nucleotide polymorphism-array and CNV-seq was performed to detected 16p11.2 deletion. For infants born carrying the 16p11.2 deletion, neurological and intellectual evaluations using the Chinese version of the Gesell Development Scale. For patients observed to have vertebral malformations, Sanger sequencing for T-C-A haplotype of TBX6 was performed. For those infants with clinical manifestations, whole-exome sequencing was consecutively performed in trios to rule out single-gene diseases, and transcriptomics combined with untargeted metabolomics were performed. Results: The prevalence of 16p11.2 deletion was 0.063% (55/86,035) in the prenatal period. Up to 80% (20/25) of the 16p11.2 deletions were proven de novo by parental confirmation. Approximately half of 16p11.2 deletions (28/55) were detected with prenatal abnormal ultrasound findings. Vertebral malformations were identified as the most distinctive structural malformations and were enriched in fetuses with 16p11.2 deletions compared with controls (90.9‰ [5/55] vs. 8.4‰ [72/85,980]; P < 0.001). All 5 fetuses with vertebral malformations were confirmed to have the TBX6 haplotype of T-C-A. Overall, 47.6% (10/21) infants birthed were diagnosed with NDDs of different degrees. Language impairment was the predominant manifestation (7/10; 70.0%), followed by motor delay (5/10; 50%). Multi-omics analysis indicated that MAPK3 was the central hub of the differentially expressed gene (DEG) network. We firstly reported that histidine-associated metabolism may be the core metabolic pathway related to the 16p11.2 deletion. Conclusion: We demonstrated the prenatal presentation, incomplete penetrance and variable expressivity of the 16p11.2 deletion. We identified vertebral malformations were the most distinctive prenatal phenotypes, and language impairment was the predominant postnatal manifestation. Most of the 16p11.2 deletion was de novo. Meanwhile, we suggested that MAPK3 and histidine-associated metabolism may contribute to neurodevelopmental abnormalities of 16p11.2 deletion.

Clinical and Molecular Characterization of De Novo Loss of Function Variants in Hnrnpu

Heterozygous HNRNPU variants cause early onset epilepsy and severe intellectual disability

A Case with 4 De Novo Copy Number Variations with Clinical Features That Overlap 1q43q44 Microdeletion and 3q29 Microduplication Syndromes.

[Clinical and Genetic Analysis of a Fetus with 17q12 Microdeletion Syndrome].

Two new cases of interstitial 7q35q36.1 deletion including CNTNAP2 and KMT2C

Case Report: Exome and RNA Sequencing Identify a Novel de novo Missense Variant in HNRNPK in a Chinese Patient With Au-Kline Syndrome

Case report: Novel NUS1 variant in a Chinese patient with tremors and intellectual disability

A Genomic Copy Number Variant Analysis Implicates the MBD5 and HNRNPUgenes in Chinese Children with Infantile Spasms and Expands the Clinical Spectrum of 2q23.1 Deletion

Two Novel Heterozygous Truncating Variants in NR4A2 Identified in Patients with Neurodevelopmental Disorder and Brief Literature Review

Novel syndromic neurodevelopmental disorder caused by de novo deletion of , a long noncoding RNA

HPDL mutations identified by exome sequencing are associated with infant neurodevelopmental disorders

Novel Variants of PPP2R1A in Catalytic Subunit Binding Domain and Genotype–Phenotype Analysis in Neurodevelopmentally Delayed Patients

Role of PUF60 Gene in Verheij Syndrome: a Case Report of the First Chinese Han Patient with a De Novo Pathogenic Variant and Review of the Literature

Phenotypic and Genetic Analysis of Four Patients with 13Q33-Q34 Microdeletion

Prenatal prevalence and postnatal manifestations of 16p11.2 deletions: A new insights into neurodevelopmental disorders based on clinical investigations combined with multi-omics analysis

Neurodevelopmental disorder caused by a truncating de novo variant of IRF2BPL

Developmental epileptic encephalopathy with hypomyelination and brain atrophy associated with PTPN23 variants affecting the assembly of UsnRNPs

Functional analysis of a novel nonsense PPP1R12A variant in a Chinese family with infantile epilepsy

A Novel de Novo Variant in 5′ UTR of the NIPBL Associated with Cornelia de Lange Syndrome

Identification of a novel de novo PUF60 variant causing Verheij syndrome in a fetus

Trio Exome Sequencing Identified a Novel De Novo WASF1 Missense Variant Leading to Recurrent Site Substitution in a Chinese Patient with Developmental Delay, Microcephaly, and Early-Onset Seizures: A Mutational Hotspot P.trp161 and Literature Review